A Case of Amyloid Myopathy Mimicking Anti-Mi-2 Antibody-Positive Myositis

Nishigaichi, Akira; Amano, Yu; Sada, Ryuichi Minoda; Miyake, Hirofumi; Maruyama, Wataru; Tagawa, Shunsuke; Akebo, Hiroyuki; Hatta, Kazuhiro; Nishino, Ichizo

doi:https://doi.org/10.1007/s11606-024-09012-1

A Case of Amyloid Myopathy Mimicking Anti-Mi-2 Antibody-Positive Myositis

Nishigaichi, Akira; Amano, Yu; Sada, Ryuichi Minoda et al.

Journal of General Internal Medicine, 2024, 40(2), 479-484

アクセス数:455件（2025-07-09 07:21 集計）

固定URL: https://hdl.handle.net/11094/98223

閲覧可能ファイル

ファイル	フォーマット	利用条件	サイズ	閲覧回数	利用開始日	説明	information
JGenInternMed_s11606-024-09012-1	pdf	なし	306 KB		2025.09.09

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

タイトル	A Case of Amyloid Myopathy Mimicking Anti-Mi-2 Antibody-Positive Myositis
著者	著者名 Nishigaichi, Akira
	著者名 Amano, Yu
	NRID 1000040961230 1000040961230 ORCID 0000-0002-1455-6822 0000-0002-1455-6822 researchmap permalink sadametal sadametal Scopus Author ID 59319135000 59319135000 著者名 Sada, Ryuichi Minoda
	著者名 Miyake, Hirofumi
	著者名 Maruyama, Wataru
	著者名 Tagawa, Shunsuke
	著者名 Akebo, Hiroyuki
	著者名 Hatta, Kazuhiro
	NRID 1000000332388 1000000332388 著者名 Nishino, Ichizo
キーワード等	Myositis
	Mi-2 antibodies
	amyloidosis
内容	This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1007/s11606-024-09012-1.
抄録	Amyloidosis is characterized by the deposition of abnormal amyloid protein in variable organs, leading to organ failures.1 Amyloid myopathy is one of the rare complications of systemic amyloidosis. It manifests as proximal muscle weakness and creatine kinase elevation, resembling idiopathic inflammatory myopathies (IIMs).2,3,4,5,6 In contrast, IIMs are autoimmune diseases characterized by inflammation in muscles, and dermatomyositis is one of the subgroups of IIMs. To date, at least seven serum markers of dermatomyositis, known as myositis-specific antibodies (MSAs), have been identified.7,8 They are known to exhibit high specificity for dermatomyositis, and anti-Mi-2 antibody is one of them.9,10 Since the treatment of dermatomyositis is immunosuppressive drugs, including glucocorticoids, whereas the treatment of AL amyloidosis requires chemotherapy, it is important to make the correct diagnosis of amyloid myopathy without misdiagnosing dermatomyositis.We encountered a case diagnosed with amyloid myopathy through muscle biopsy, despite testing positive for the anti-Mi-2 antibody. This case highlights the potential for false-positive results in myositis-specific antibody tests and emphasizes the importance of advancing clinical reasoning beyond sole reliance on antibody testing.Informed consent was obtained from the patient for publication of the report and associated images.
出版者	Springer
収録物名	Journal of General Internal Medicine
巻(号)	40(2)
ページ	479-484
刊行年月	2024-09-09
言語	英語
ハンドルURL	https://hdl.handle.net/11094/98223
PISSN	08848734
eISSN	15251497
関連情報 (isVersionOf)	DOI (出版社版) https://doi.org/10.1007/s11606-024-09012-1
アクセス権	embargoed access
権利情報	The full-text file will be made open to the public on 9 September 2025 in accordance with the publisher's policy.
出版タイプ	Accepted Manuscript
カテゴリ	学術雑誌論文 Journal Article

資源タイプ	学術雑誌論文
ローカル資源タイプ	学術雑誌論文
DCTERMS.bibliographicCitation	Journal of General Internal Medicine. 2024, 40(2), p. 479-484
DC.title	A Case of Amyloid Myopathy Mimicking Anti-Mi-2 Antibody-Positive Myositis
DC.creator	Nishigaichi, Akira
	Amano, Yu
	Sada, Ryuichi Minoda
	Miyake, Hirofumi
	Maruyama, Wataru
	Tagawa, Shunsuke
	Akebo, Hiroyuki
	Hatta, Kazuhiro
	Nishino, Ichizo
DC.publisher	Springer
DC.language' scheme='DCTERMS.RFC1766	英語
DCTERMS.issued' scheme='DCTERMS.W3CDTF	2024-09-09
DC.identifier	https://doi.org/10.1007/s11606-024-09012-1
DC.subject	Myositis
	Mi-2 antibodies
	amyloidosis
DC.description	This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1007/s11606-024-09012-1.
DCTERMS.abstract	Amyloidosis is characterized by the deposition of abnormal amyloid protein in variable organs, leading to organ failures.1 Amyloid myopathy is one of the rare complications of systemic amyloidosis. It manifests as proximal muscle weakness and creatine kinase elevation, resembling idiopathic inflammatory myopathies (IIMs).2,3,4,5,6 In contrast, IIMs are autoimmune diseases characterized by inflammation in muscles, and dermatomyositis is one of the subgroups of IIMs. To date, at least seven serum markers of dermatomyositis, known as myositis-specific antibodies (MSAs), have been identified.7,8 They are known to exhibit high specificity for dermatomyositis, and anti-Mi-2 antibody is one of them.9,10 Since the treatment of dermatomyositis is immunosuppressive drugs, including glucocorticoids, whereas the treatment of AL amyloidosis requires chemotherapy, it is important to make the correct diagnosis of amyloid myopathy without misdiagnosing dermatomyositis.We encountered a case diagnosed with amyloid myopathy through muscle biopsy, despite testing positive for the anti-Mi-2 antibody. This case highlights the potential for false-positive results in myositis-specific antibody tests and emphasizes the importance of advancing clinical reasoning beyond sole reliance on antibody testing.Informed consent was obtained from the patient for publication of the report and associated images.
DC.rights	The full-text file will be made open to the public on 9 September 2025 in accordance with the publisher's policy.
DC.format	98223
citation_title	A Case of Amyloid Myopathy Mimicking Anti-Mi-2 Antibody-Positive Myositis
citation_author	Nishigaichi, Akira
	Amano, Yu
	Sada, Ryuichi Minoda
	Miyake, Hirofumi
	Maruyama, Wataru
	Tagawa, Shunsuke
	Akebo, Hiroyuki
	Hatta, Kazuhiro
	Nishino, Ichizo
citation_publisher	Springer
citation_language	英語
citation_date	2024-09-09
citation_journal_title	Journal of General Internal Medicine
citation_volume	40
citation_issue	2
citation_firstpage	479
citation_lastpage	484
citation_doi	https://doi.org/10.1007/s11606-024-09012-1
citation_public_url	https://hdl.handle.net/11094/98223

A Case of Amyloid Myopathy Mimicking Anti-Mi-2 Antibody-Positive Myositis

閲覧可能ファイル

論文情報

論文詳細を表示